Company: GRCE
Filing Date: 2025-07-28
Form Type: DEF 14A
Source: 0001140361-25-027456
Chunk: 42

Company: Grace Therapeutics, Inc.
Filing Date: 2025-07-28
Form: DEF 14A
Chunk 42
---
 Pay Versus Performance As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Company. The following table sets forth information concerning Compensation Actually Paid (“CAP”) to our PEOs and non-PEO NEOs versus our total shareholder return (“TSR”) and net income (loss) performance results for the fiscal years ended March 31, 2025, 2024, and 2023. The amounts set forth below under the headings “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to Non-PEO NEOs have been calculated in a manner consistent with Item 402(v) of Regulation S-K. Use of the term CAP is required by the SEC’s rules and as a result of the calculation methodology required by the SEC, such amounts differ from compensation actually received by the individuals and the compensation decisions described in the “—Narrative to Summary Compensation Table” section above.

| Year           |     |      Summary 
 compensation 
  table total 
   for Former 
       PEO(1) 
          ($) |     | Compensation 
     actually 
      paid to 
       Former 
       PEO(1) 
          ($) |     |      Summary 
 compensation 
  table total 
  for Current 
       PEO(2) 
          ($) |     | Compensation 
     actually 
      paid to 
      Current 
       PEO(2) 
          ($) |     |      Average 
      summary 
 compensation 
  table total 
  for non-PEO 
      NEOs(3) 
          ($) |     |      Average 
 compensation 
     actually 
 paid to non- 
  PEO NEOs(3) 
          ($) |     |    Value of 
     initial 
  fixed $100 
  investment 
   based on: 
       Total 
 shareholder 
      return 
    (TSR)(4) 
         ($) |     |            Net 
         income 
         (loss) 
 ($ in 000s)(5) |
| March 31, 2025 |     |            — |     |            — |     |    1,074,621 |     |      744,663 |     |      421,563 |     |      360,827 |     |       31.15 |     |         -9